Goldman Sachs has asked its UK employees to divulge their Covid-19 vaccine status, but the bank’s City operation has stopped short of mandating employees disclose whether or not they have had the jab as it has done in the US.
The bank’s US-based employees are required to reveal whether or not they have been vaccinated against Covid-19 by midday on 10 June local time, as part of its efforts to ramp up office-based staff over the summer, according to a memo sent to staff in the country.
“While we strongly encourage you to receive a Covid-19 vaccine, we understand that the choice to get vaccinated is a personal one,” the memo sent to US employees read.
“If you have registered all required doses of your vaccine and are considered fully vaccinated, you will no longer be required to participate in the on-site testing program and, if local requirements allow, you will no longer be required to wear a mask while in the office,” it added.
In the UK, Goldman has already increased staff numbers to around 35% of its 6,000-or-so UK-based employees after telling them to “make plans to be in a position to return to the office” by 21 June.
UK staff are not mandated to reveal their vaccination status, but the bank has been conducting a survey of its staff on a voluntary basis since the end of May, according to a separate memo seen by Financial News, with employees “strongly encouraged” to reveal whether or not they have had the jab.
The survey gives employees the option of not revealing their vaccination status and responses are anonymous.
“There is increasing evidence that vaccination significantly reduces infection risk,” the memo said. “Therefore, the vaccination uptake rate for our PTC [Plumtree Court, European headquarters] population is an important health and safety metric in the design of health and safety protocols. To assist the firm’s health and safety planning, you are strongly encouraged to complete this survey on your vaccination status.”
Goldman Sachs has already offered employees half a day off to receive their Covid-19 vaccination, a move also taken by US peer JPMorgan.
To contact the author of this story with feedback or news, email Paul Clarke